Global Pompe Disease Treatment market [2016-2030] by Middle East and Africa

Growth Outlook

• The 2030] by Middle East and Africa portion of the Global Pompe Disease Treatment market [2016 market is on a steady long-term growth path. Segment value stands at roughly USD 288 Mn in 2026 and is projected to reach USD 316 Mn by 2030 — a gain of about 10% over the forecast period, translating to a CAGR in the low single digits.
• Middle-East accounted for the larger market share in 2018 in the Middle East and Africa pompe disease treatment market, and is expected to reach USD 125. 00 Million in 2030 from USD 98.
• What the regional split looks like (2026): Middle East and Africa leads, holding roughly 50% of segment value — the single largest regional share. Middle-East is the second-largest contributor. Africa make up the remainder, in descending order.
• By 2030, Middle East and Africa alone is expected to reach USD 158 Mn, with Middle-East at USD 125 Mn.

Market Dynamics

Middle-East accounted for the larger market share in 2018 in the Middle East and Africa pompe disease treatment market, and is expected to reach USD 125.00 Million in 2030 from USD 98.50 Million in 2018.This market is projected to grow at a CAGR of 2.05% during the forecast period from 2019 - 2030. late onset pompe disease segment accounted for the largest market share in 2018, this market is expected to reach USD 95.70 Million in 2030 from USD 74.80 Million in 2018. This market is projected to grow at a CAGR of 2.12% during the forecast period from 2019 - 2030. However, late onset pompe disease segment is the fastest growing market, which is expected to grow at a CAGR of 2.12% during the forecast period 2019 - 2030. hospitals and clinics segment accounted for the larger market share in 2018, this market is expected to reach USD 116.70 Million in 2030 from USD 91.10 Million in 2018. This market is projected to grow at a CAGR of 2.13% during the forecast period from 2019 - 2030.

However, hospitals and clinics segment is the fastest growing market, which is expected to grow at a CAGR of 2.13% during the forecast period 2019 - 2030. enzyme replacement therapy ert segment accounted for the largest market share in 2018, this market is expected to reach USD 111.00 Million in 2030 from USD 88.50 Million in 2018. This market is projected to grow at a CAGR of 1.96% during the forecast period from 2019 - 2030. However, gene therapy segment is the fastest growing market, which is expected to grow at a CAGR of 2.21% during the forecast period 2019 - 2030.

Research Methodology

Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.